Singapore's Duke-NUS research unlocks precision therapy for drug-resistant leukaemia

Scientists from Singapore's Duke-NUS Medical School and their collaborators have identified an inherited genetic variati...

November 7, 2024 | Thursday | News
“Moving forward, cancer may not be a death threat but a manageable disease with strong control”

Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...

October 31, 2024 | Thursday | Opinion
Digital Innovations in Diabetes Care

Diabetes affects 1 in 11 adults, or about 90 million people, in South-East Asia, with this number projected to rise to 1...

October 31, 2024 | Thursday | Analysis
Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
Seaport Therapeutics secures $225 M funding to develop neuropsychiatric medicines using prodrug technology

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...

October 26, 2024 | Saturday | News
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...

October 22, 2024 | Tuesday | News
Isolere Bio by Donaldson Launches Research-Grade IsoTagâ„¢ AAV Reagent for Rapid, Non-Chromatographic Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...

October 18, 2024 | Friday | News
Singapore discovers novel gene therapy offering hope for epilepsy patients

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) are working on a t...

October 15, 2024 | Tuesday | News
Caring Cross Champions Healthcare Equity: Dr. Boro Dropulić on Reshaping CAR-T Cell Therapies Through Decentralized Manufacturing

In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cr...

October 14, 2024 | Monday | News
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...

October 13, 2024 | Sunday | News
National University of Singapore and Imperial College London establish major research partnership

National University of Singapore (NUS) and Imperial College London have announced a new partnership to strengthen resear...

October 13, 2024 | Sunday | News
Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

October 11, 2024 | Friday | News
$18 M investment for world-first Australian research project for heart attack protection

The government is investing almost $18 million in a world-first Australian research project that will trial a drug disco...

October 7, 2024 | Monday | News
Singapore strategises advance modalities for cancer- and age-related muscle degeneration

Caption : Duke-NUS PhD candidate Ms Lee Wen Xing (front) characterised the DEAF1 phenotype in Drosophila after...

September 26, 2024 | Thursday | News
Bio-Sourcing secures EIC Accelerator funding to enhance biomanufacturing

Bio-Sourcing, a pioneering Belgian biotherapeutic company, announces the award of €2.5M in grants and €10M in ...

September 24, 2024 | Tuesday | News
Antibody Engineering & Therapeutics Asia 2024: A Premier Gathering for Cutting-Edge Antibody Research and Innovation

Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...

September 1, 2024 | Sunday | News
Australia designs world first wearable device to record impact of artificial light for sound sleep

In a world first, a new wearable device developed by Australia's Monash University researchers will help to record the i...

August 25, 2024 | Sunday | News
Singapore approves GSK's Jemperli plus chemotherapy as first frontline immuno-oncology treatment

GSK Singapore has announced that the Singapore Health Sciences Authority (HSA) has approved a new indication for Jemperl...

August 8, 2024 | Thursday | News
Andelyn Biosciences Expands AAV Curatorâ„¢ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News
Abu Dhabi announces first gene transfer therapy for duchenne muscular dystrophy

Department of Health – Abu Dhabi (DoH) has provided revolutionary gene transfer therapy for Duchenne muscular dyst...

August 6, 2024 | Tuesday | News
Boston Oncology to advance localised cell and gene therapies in Saudi Arabia

Under an important initiative aimed at transforming healthcare in the Kingdom of Saudi Arabia, Boston Oncology and King ...

August 2, 2024 | Friday | News
Singapore MOH includes Roche's spinal muscular atrophy (SMA) drug in MAF framework

EVRYSDI® (risdiplam) has been added to the Singapore Ministry of Health’s (MOH) list of medicines covered...

August 1, 2024 | Thursday | News
Addressing Root Causes of Brain Disorders with Innovative Therapeutics

The global CNS disorders market, in 2022, was valued at $116 billion, ranking it as the fourth largest therapy area behi...

August 1, 2024 | Thursday | Analysis
Hong Kong researchers suggest novel treatment approaches for glaucoma

Dr Samantha SHAN, Research Assistant Professor of the School of Optometry of The Hong Kong Polytechnic University (PolyU...

July 27, 2024 | Saturday | News
China-based startup Triastek to advance 3D printed oral RNA therapeutics in $1.2 B deal with BioNTech

Triastek Inc., a global leader in 3D printing pharmaceuticals, has entered into a research collaboration and platform te...

July 23, 2024 | Tuesday | News